Complete ICD-10-CM coding and documentation guide for Verotoxin. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Verotoxin
Escherichia coli as the cause of diseases classified elsewhere
This range includes codes for infections caused by Shiga toxin-producing E. coli, including specific serotypes like O157.
Enterocolitis due to Shiga toxin-producing Escherichia coli
This code is used when gastrointestinal symptoms are the primary manifestation of the infection.
Hemolytic-uremic syndrome
This code is used when hemolytic-uremic syndrome is the primary manifestation of the infection.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
B96.21 | Shiga toxin-producing Escherichia coli [STEC] O157 | Use when STEC O157 is confirmed and linked to clinical manifestations. |
|
A04.3 | Enterocolitis due to Shiga toxin-producing Escherichia coli | Use when gastrointestinal symptoms are the primary manifestation. |
|
D59.3 | Hemolytic-uremic syndrome | Use when HUS is the primary manifestation. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Verotoxin
Use when gastrointestinal symptoms are the primary manifestation.
Ensure documentation of gastrointestinal symptoms.
Use when HUS is the primary manifestation.
Ensure documentation of HUS symptoms and STEC confirmation.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Avoid these common documentation and coding issues when documenting Verotoxin to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code B96.21.
Clinical: May lead to incorrect treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Always confirm serotype with lab tests., Include specific serotype in documentation.
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Ensure lab confirmation of O157 serotype before coding.
Reimbursement: Potential underpayment for services rendered., Compliance: Failure to follow coding guidelines., Data Quality: Incomplete clinical data capture.
Always pair A04.3 with B96.21 for confirmed STEC.
Coding O157 without lab confirmation.
Require lab confirmation before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Verotoxin, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Verotoxin. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Verotoxin? Ask your questions below.